Title: Collaborative Pharmacy Practice for Chronic Health Conditions

Summary: Revising the definition of the term "chronic health condition" to exclude specified heart conditions for purposes of collaborative pharmacy practice for chronic health conditions, etc.

Full Text:
An act relating to collaborative pharmacy practice for chronic health conditions; amending s. 465.1865, F.S.; revising the definition of the term  chronic health condition  to exclude specified heart conditions for purposes of collaborative pharmacy practice for chronic health conditions; providing an effective date. Be It Enacted by the Legislature of the State of Florida: Section 1. Paragraph (b) of subsection (1) of section 465.1865, Florida Statutes, is amended to read: 465.1865 Collaborative pharmacy practice for chronic health conditions.  (1) For purposes of this section, the term: (b) Chronic health condition  means: 1. Arthritis; 2. Asthma; 3. Chronic obstructive pulmonary diseases; 4. Type diabetes; 5. Human immunodeficiency virus or acquired immune deficiency syndrome; 6. Obesity; or 7. Any other chronic condition adopted in rule by the board, in consultation with the Board of Medicine and the Board of Osteopathic Medicine. The term does not include heart failure, coronary heart disease, or a cardiac rhythm disorder. Section 2. This act shall take effect July 1, 2025.